Vertex to Present at Upcoming Investor Conferences
September 09 2016 - 3:30PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that management will present at The Morgan Stanley Global
Healthcare Conference in New York, NY on Wednesday, September 14th
at 11:40 a.m. ET. Vertex will also present at The Leerink Partners
Roundtable Series in New York, NY on Wednesday, September 28th at
3:40 p.m. ET.
Management's remarks will be accessible live through Vertex's
website at www.vrtx.com in the "Investors" section under
the "Events and Presentations" page. A replay of the conference
webcast will be archived on the company's website.
About Vertex
Vertex is a global biotechnology company that aims to discover,
develop and commercialize innovative medicines so people with
serious diseases can lead better lives. In addition to our clinical
development programs focused on cystic fibrosis, Vertex has more
than a dozen ongoing research programs aimed at other serious and
life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has
research and development sites and commercial offices in the
United States, Europe, Canada and Australia. For
five years in a row, Science magazine has named Vertex
one of its Top Employers in the life sciences. For additional
information and the latest updates from the company, please
visit www.vrtx.com.
(VRTX-GEN)
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160909005889/en/
Vertex Pharmaceuticals
IncorporatedInvestors:Michael Partridge,
617-341-6108orEric Rojas, 617-961-7205orZach Barber,
617-341-6470
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024